Disclosures for "Progressive Perivascular Enhancement in KLHL11 Encephalitis: A Case of Delayed Seminoma Recurrence Presenting as Autoimmune Encephalitis"
-
Dr. Nittala has nothing to disclose.
-
Dr. Baldwin has received personal compensation in the range of $500-$4,999 for serving as a volunteer international neurology instructor with CMDA, MAP International, and INMED (NGOs).
-
Dr. Mahmoudi has received personal compensation for serving as an employee of University of Miami.
-
Dr. Statz-Geary has nothing to disclose.
-
Dr. Salazar has nothing to disclose.
-
Dr. Borja has nothing to disclose.
-
The institution of Dr. BILUSIC has received research support from Merck, Inc. The institution of Dr. BILUSIC has received research support from Marengo Therapeutics. The institution of Dr. BILUSIC has received research support from Hookipa Pharma . The institution of Dr. BILUSIC has received research support from Eli Lilly. The institution of Dr. BILUSIC has received research support from Bicycle Therapeutics. The institution of Dr. BILUSIC has received research support from Clasp Therpeutics .
-
Dr. Alshiekh Nasany has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J&J.
-
Dr. Suarez has nothing to disclose.
-
Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.